Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes

Pediatric Diabetes

Volumn 10, Issue 2, 2009, Pages 116-119

  Burdick, Patricia ^a   Cooper, Sonia ^a   Horner, Brian ^a   Cobry, Erin ^a   Mcfann, Kim ^a   Chase, H Peter ^a,b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b NONE   (United States)

Author keywords

Children; HbA1c; Insuflon; T1D

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; NEUTRAL INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE METER; CHILD; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INFUSION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CATHETERS, INDWELLING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 61549142976     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00449.x     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005: 353: 2643-2653.
3. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177-188.
4. Chase HP. Glycemic control in prepubertal years. Diabetes Care 2003: 4: 1304.
5. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2007: 5 (Suppl. 1): S4-S41.
6. Zambanini A. Needle phobia in type 1 diabetes mellitus. Diabet Med 1977: 14: 321-323.
7. Burdick J, Chase HP, Slover RH et al. Missed insulin meal boluses and elevated hemoglobin HbA1c levels in children receiving insulin pump Etherapy. Pediatrics 2004: 113: e221-e224.
8. Chase HP, Horner B, McFann K et al. The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 2006: 29: 1012-1015.
9. Chase HP, Dixon B, Pearson J et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn. J Pediatr 2003: 143: 737-740.
10. Dixon B, Chase HP, Burdick J et al. Use of insulin glargine in children under age six with type 1 diabetes. Pediatr Diabetes 2005: 6: 150-154.
11. Diabetes Research Network in Children Study Group. Comparison of fingerstick hemoglobin HbA1c levels assayed by DCA 2000 with the DCCT/ EDIC central laboratory assay: Results of a Diabetes Research Network in Children (DirecNet) Study. Pediatr Diabetes 2005: 6: 13-16.
12. Hanas SR, Ludvigsson J. Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract Diabetes 1997: 14: 95-99.
13. Hanas SR, Carlsson S, Frid A, Ludvigsson J. Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections. Diabetes Care 1997: 20: 487-490.
14. Hanas SR, Adolfsson P, Elfvin-Akesson K et al. Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety. J Pediatr 2002: 140: 315-320.
15. Hanas SR, Ludvigsson J. Metabolic control is not altered when using indwelling catheters for insulin injections. Diabetes Care 1994: 17: 716-718.
16. Kaplan W, Rodriguez L, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004: 27: 2739-2740.
17. Fiallo-Scharer R, Horner B, McFann K, Walravens P, Chase HP. Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. J Pediatr 2006: 148: 481-484.